PAB 0.00% 0.3¢ patrys limited

Ann: Patrys - Details of PAT-SM6 & Carfilzomib Clinical Trial, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,043 Posts.
    lightbulb Created with Sketch. 249
    I understand the negativity but I for one acknowledge the immense effort undertaken by Patrys to progress the development of their antibody into this clinical trial.

    True enough the announcement has done nothing for the SP but the fact that Onyx are prepared to investigate this combo is enough for me to leave my stash where it is. MM is a nasty disease and I wish the trial and its participants every success.

    And of course, if they meet the trial objective s, we win big!
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $6.172M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $16.52K 5.509M

Buyers (Bids)

No. Vol. Price($)
29 58406173 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 10870910 15
View Market Depth
Last trade - 11.22am 07/11/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.